dihexa lipophilic peptidomimetic Growth factors and their peptide mimetics for treatment of traumatic brain injury Dihexa (PNB-0408) | c-Met/HGFR Activator

Memantine and cholinesterase inhibitor combination therapy for Alzheimer's disease: a systematic review

Already present

Clinical observations suggest splitting doses or evening administration reduces efficacy by 2535% due to circadian misalignment with endogenous NAD+ synthesis pathways

During the first two months of follow-up, there was no significant difference between the two groups

It was originally identified as a fragment derived from a larger protein found in human gastric juice, which sparked early scientific interest due to its unusual stability and biological activity under experimental conditions

Julie was very professional and informative